Data mining for identifying novel associations and temporal relationships with charcot foot

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Munson, Michael E ^a   Wrobel, James S ^a   Holmes, Crystal M ^a   Hanauer, David A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHARCOT FOOT; COHORT ANALYSIS; DATA MINING; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HUMAN; ICD-9; LOEFFLER PNEUMONIA; NEUROPATHIC JOINT DISEASE; PATHOGENESIS; ANKLE; BIOLOGICAL MODEL; DELAYED DIAGNOSIS; DIABETIC FOOT; DIAGNOSTIC ERROR; FOOT; HYPOVOLEMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; RISK FACTOR; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AMBULATORY CARE FACILITIES; ANKLE; ARRHYTHMIAS, CARDIAC; ARTHROPATHY, NEUROGENIC; COHORT STUDIES; DATA MINING; DELAYED DIAGNOSIS; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIAGNOSTIC ERRORS; ELECTRONIC HEALTH RECORDS; FOOT; HUMANS; HYPOVOLEMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; MICHIGAN; MODELS, BIOLOGICAL; PULMONARY EOSINOPHILIA; RISK FACTORS;

EID: 84900992993     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/214353     Document Type: Article

References (40)

1. Lavery L. A., Armstrong D. G., Wunderlich R. P., Tredwell J., Boulton A. J. M., Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003 26 5 1435 1438 2-s2.0-0041667929 10.2337/diacare.26.5.1435 (Pubitemid 36929175)
2. Fabrin J., Larsen K., Holstein P. E., Long-term follow-up in diabetic charcot feet with spontaneous onset. Diabetes Care 2000 23 6 796 800 2-s2.0-0034125049 (Pubitemid 30414196)
3. Sinha S., Munichoodappa C. S., Kozak G. P., Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine 1972 51 3 191 210 2-s2.0-0015333904
4. Frykberg R. G., Belczyk R., Epidemiology of the Charcot foot. Clinics in Podiatric Medicine and Surgery 2008 25 1 17 28 2-s2.0-37349073762 10.1016/j.cpm.2007.10.001 (Pubitemid 350299816)
5. Stuck R. M., Sohn M., Budiman-Mak E., Lee T. A., Weiss K. B., Charcot arthropathy risk elevation in the obese diabetic population. The American Journal of Medicine 2008 121 11 1008 1014 2-s2.0-54349098440 10.1016/j.amjmed.2008.06.038
6. Matricali G. A., Bammens B., Kuypers D., Flour M., Mathieu C., High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation. Transplantation 2007 83 2 245 246 2-s2.0-33846567461 10.1097/01.tp.0000244730.95416.c6 (Pubitemid 46185226)
7. Ramani R. G., Jacob S. G., Data mining in clinical data sets: a review. International Journal of Applied Information Systems 2012 4 6 15 26
8. Jensen P. B., Jensen L. J., Brunak S., Mining electronic health records: towards better research applications and clinical care. Nature Reviews Genetics 2012 13 6 395 405 2-s2.0-84860549397 10.1038/nrg3208
9. Mullins I. M., Siadaty M. S., Lyman J., Scully K., Garrett C. T., Miller W. G., Muller R., Robson B., Apte C., Weiss S., Rigoutsos I., Platt D., Cohen S., Knaus W. A., Data mining and clinical data repositories: insights from a 667,000 patient data set. Computers in Biology and Medicine 2006 36 12 1351 1377 2-s2.0-33748937391 10.1016/j.compbiomed.2005.08.003 (Pubitemid 44436114)
10. Hanauer D. A., Ramakrishnan N., Modeling temporal relationships in large scale clinical associations. Journal of the American Medical Informatics Association 2013 20 2 332 341 10.1136/amiajnl-2012-001117
11. Hanauer D. A., Rhodes D. R., Chinnaiyan A. M., Exploring clinical associations using "-omics" based enrichment analyses. PLoS ONE 2009 4 4 2-s2.0-65249119617 10.1371/journal.pone.0005203 e5203
12. Shannon P., Markiel A., Ozier O., Baliga N. S., Wang J. T., Ramage D., Amin N., Schwikowski B., Ideker T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003 13 11 2498 2504 2-s2.0-0242490780 10.1101/gr.1239303 (Pubitemid 37428274)
13. McEwen L. N., Ylitalo K. R., Herman W. H., Wrobel J. S., Prevalence and risk factors for diabetes-related foot complications in Translating Research Into Action for Diabetes (TRIAD). Journal of Diabetes and Its Complications 2013 27 6 588 592 10.1016/j.jdiacomp.2013.08.003
14. Pinzur M. S., Benchmark analysis of diabetic patients with neuropathic (Charcot) foot deformity. Foot and Ankle International 1999 20 9 564 567 2-s2.0-0032836516 (Pubitemid 29449231)
15. Sohn M., Lee T. A., Stuck R. M., Frykberg R. G., Budiman-Mak E., Mortality risk of charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care 2009 32 5 816 821 2-s2.0-65949087231 10.2337/dc08-1695
16. Sohn M. W., Stuck R. M., Pinzur M., Lee T. A., Budiman-Mak E., Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer. Diabetes Care 2010 33 1 98 100 2-s2.0-74249117105 10.2337/dc09-1497
17. Rhodes E. T., Laffel L. M. B., Gonzalez T. V., Ludwig D. S., Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults. Diabetes Care 2007 30 1 141 143 2-s2.0-33845985619 10.2337/dc06-1142 (Pubitemid 46052513)
18. Botek G., Anderson M. A., Taylor R., Charcot neuroarthropathy: an often overlooked complication of diabetes. Cleveland Clinic Journal of Medicine 2010 77 9 593 599 2-s2.0-77956509369 10.3949/ccjm.77a.09163
19. Iavindrasana J., Cohen G., Depeursinge A., Müller H., Meyer R., Geissbuhler A., Clinical data mining: a review. Yearbook of Medical Informatics 2009 121 133 2-s2.0-77950519462
20. Hanauer D. A., Ramakrishnan N., Seyfried L. S., Describing the relationship between cat bites and human depression using data from an electronic health record. PLoS ONE 2013 8 8 e70585 10.1371/journal.pone.0070585
21. Tatonetti N. P., Ye P. P., Daneshjou R., Altman R. B., Data-driven prediction of drug effects and interactions. Science Translational Medicine 2012 4 125 2-s2.0-84858329412 10.1126/scitranslmed.3003377 125ra31
22. Wright A., Chen E. S., Maloney F. L., An automated technique for identifying associations between medications, laboratory results and problems. Journal of Biomedical Informatics 2010 43 6 891 901 2-s2.0-78649328064 10.1016/j.jbi.2010.09.009
23. Chantelau E., Onvlee G. J., Charcot foot in diabetes: farewell to the neurotrophic theory. Hormone and Metabolic Research 2006 38 6 361 367 2-s2.0-33745876824 10.1055/s-2006-944525 (Pubitemid 44047957)
24. Koeck F. X., Bobrik V., Fassold A., Grifka J., Kessler S., Straub R. H., Marked loss of sympathetic nerve fibers in chronic charcot foot of diabetic origin compared to ankle joint osteoarthritis. Journal of Orthopaedic Research 2009 27 6 736 741 2-s2.0-66249140901 10.1002/jor.20807
25. Rogers L. C., Frykberg R. G., Armstrong D. G., Boulton A. J., Edmonds M., Van G. H., Hartemann A., Game F., Jeffcoate W., Jirkovska A., Jude E., Morbach S., Morrison W. B., Pinzur M., Pitocco D., Sanders L., Wukich D. K., Uccioli L., The Charcot foot in diabetes. Diabetes Care 2011 34 9 2123 2129 10.2337/dc11-0844
26. Navone S. E., Marfia G., Canzi L., Ciusani E., Canazza A., Visintini S., Campanella R., Parati E. A., Expression of neural and neurotrophic markers in nucleus pulposus cells isolated from degenerated intervertebral disc. Journal of Orthopaedic Research 2012 30 9 1470 1477 2-s2.0-84857415061 10.1002/jor.22098
27. Gilbert M. E., Lasley S. M., Developmental thyroid hormone insufficiency and brain development: a role for brain-derived neurotrophic factor (BDNF)? Neuroscience 2013 239 253 270 10.1016/j.neuroscience.2012.11.022
28. Antunes-Lopes T., Pinto R., Barros S. C., Botelho F., Silva C. M., Cruz C. D., Cruz F., Urinary neurotrophic factors in healthy individuals and patients with overactive bladder. Journal of Urology 2013 189 1 359 365 10.1016/j.juro.2012.08.187
29. de Groat W. C., Yoshimura N., Afferent nerve regulation of bladder function in health and disease. Handbook of Experimental Pharmacology 2009 194 91 138 2-s2.0-70349904585 10.1007/978-3-540-79090-7-4
30. Mabilleau G., Petrova N., Edmonds M. E., Sabokbar A., Number of circulating CD 14-positive cells and the serum levels of TNF- are raised in acute charcot foot. Diabetes Care 2011 34 3, article e33 2-s2.0-79956130397 10.2337/dc10-1695
31. Ndip A., Williams A., Jude E. B., Serracino-Inglott F., Richardson S., Smyth J. V., Boulton A. J. M., Alexander M. Y., The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic charcot neuroarthropathy. Diabetes 2011 60 8 2187 2196 2-s2.0-80052829942 10.2337/db10-1220
32. Kaptoge S., Di Angelantonio E., Lowe G., Pepys M. B., Thompson S. G., Collins R., Danesh J., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet 2010 375 9709 132 140 10.1016/S0140-6736(09)61717-7
33. Mandosi E., Fallarino M., Gatti A., Carnovale A., Rossetti M., Lococo E., Buchetti B., Filetti S., Lenti L., Morano S., Atorvastatin downregulates monocyte CD36 expression, nuclear NF B and TNF levels in type 2 diabetes. Journal of Atherosclerosis and Thrombosis 2010 17 6 539 545 2-s2.0-77954710883
34. Yanagi K., Monden T., Ikeda S., Matsumura M., Kasai K., A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes. Advances in Therapy 2011 28 2 160 171 2-s2.0-79952536047 10.1007/s12325-010-0098-2
35. Hamano T., Fujii N., Matsui I., Nakano C., Inoue K., Tomida K., Mikami S., Okada N., Tsubakihara Y., Rakugi H., Isaka Y., Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan. Therapeutic Apheresis and Dialysis 2011 15 supplement 1 2 8 2-s2.0-79956222032 10.1111/j.1744-9987.2011.00918.x
36. Omron E. M., Comparative quantitative acid-base analysis in coronary artery bypass, severe sepsis, and diabetic ketoacidosis. Journal of Intensive Care Medicine 2005 20 6 317 326 2-s2.0-33644836695
37. Ebeling P. R., Erbas B., Hopper J. L., Wark J. D., Rubinfeld A. R., Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. Journal of Bone and Mineral Research 1998 13 8 1283 1289 2-s2.0-0031825521 10.1359/jbmr.1998.13.8.1283 (Pubitemid 28373330)
38. Dente F. L., Bacci E., Bartoli M. L., Cianchetti S., Costa F., Di Franco A., Malagrinò L., Vagaggini B., Paggiaro P., Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma. Annals of Allergy, Asthma and Immunology 2010 104 6 464 470 2-s2.0-77953141236 10.1016/j.anai.2010.04.003
39. Targownik L. E., Leslie W. D., Davison K. S., Goltzman D., Jamal S. A., Kreiger N., Josse R. G., Kaiser S. M., Kovacs C. S., Prior J. C., Zhou W., The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis study (CaMos). The American Journal of Gastroenterology 2012 107 9 1361 1369 10.1038/ajg.2012.200
40. Wukich D. K., Sung W., Wipf S. A., Armstrong D. G., The consequences of complacency: managing the effects of unrecognized Charcot feet. Diabetic Medicine 2011 28 2 195 198 2-s2.0-78651104191 10.1111/j.1464-5491.2010.03141.x